1. Home
  2. KMDA vs PRCH Comparison

KMDA vs PRCH Comparison

Compare KMDA & PRCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • PRCH
  • Stock Information
  • Founded
  • KMDA 1990
  • PRCH 2012
  • Country
  • KMDA Israel
  • PRCH United States
  • Employees
  • KMDA N/A
  • PRCH N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • PRCH Computer Software: Prepackaged Software
  • Sector
  • KMDA Health Care
  • PRCH Technology
  • Exchange
  • KMDA Nasdaq
  • PRCH Nasdaq
  • Market Cap
  • KMDA 426.0M
  • PRCH 438.3M
  • IPO Year
  • KMDA N/A
  • PRCH N/A
  • Fundamental
  • Price
  • KMDA $6.71
  • PRCH $7.14
  • Analyst Decision
  • KMDA Strong Buy
  • PRCH Strong Buy
  • Analyst Count
  • KMDA 3
  • PRCH 8
  • Target Price
  • KMDA $14.67
  • PRCH $7.03
  • AVG Volume (30 Days)
  • KMDA 139.3K
  • PRCH 2.4M
  • Earning Date
  • KMDA 03-05-2025
  • PRCH 05-07-2025
  • Dividend Yield
  • KMDA 2.99%
  • PRCH N/A
  • EPS Growth
  • KMDA 66.67
  • PRCH N/A
  • EPS
  • KMDA 0.25
  • PRCH N/A
  • Revenue
  • KMDA $160,953,000.00
  • PRCH $437,848,000.00
  • Revenue This Year
  • KMDA $11.45
  • PRCH N/A
  • Revenue Next Year
  • KMDA $9.94
  • PRCH $22.83
  • P/E Ratio
  • KMDA $26.77
  • PRCH N/A
  • Revenue Growth
  • KMDA 12.93
  • PRCH 1.75
  • 52 Week Low
  • KMDA $4.74
  • PRCH $1.05
  • 52 Week High
  • KMDA $9.15
  • PRCH $8.49
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 44.68
  • PRCH 58.62
  • Support Level
  • KMDA $6.44
  • PRCH $7.02
  • Resistance Level
  • KMDA $7.17
  • PRCH $7.76
  • Average True Range (ATR)
  • KMDA 0.20
  • PRCH 0.61
  • MACD
  • KMDA -0.02
  • PRCH 0.03
  • Stochastic Oscillator
  • KMDA 37.36
  • PRCH 53.68

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions.

Share on Social Networks: